The stock of PuriCore plc (LON:PURI) is a huge mover today! The stock decreased 1.89% or GBX 0.5 on November 8, hitting GBX 26. About 40,000 shares traded hands or 26.82% up from the average. PuriCore plc (LON:PURI) has risen 2.91% since April 8, 2016 and is uptrending. It has outperformed by 0.96% the S&P500.
The move comes after 5 months negative chart setup for the GBX 12.98M company. It was reported on Nov, 8 by Barchart.com. We have GBX 22.62 PT which if reached, will make LON:PURI worth GBX 1.69M less.
More recent PuriCore plc (LON:PURI) news were published by: Marketwired.com which released: “PuriCore Successfully Completes Pre-IND Meeting With the FDA on PR022 for …” on June 09, 2016. Also Prnewswire.com published the news titled: “Cantel Medical Enters Into Definitive Agreement To Acquire PuriCore …” on June 04, 2014. Prnewswire.com‘s news article titled: “Cantel Medical Completes Acquisition Of PuriCore International Ltd.” with publication date: July 01, 2014 was also an interesting one.
PuriCore Plc is a biopharmaceutical firm engaged in leveraging its immunomodulatory technology to protect and improve the health of adults and children. The company has a market cap of 12.98 million GBP. The Firm is also engaged in development of small molecule therapies in inflammatory diseases with application in dermatology, ophthalmology and rare diseases, and also for applicability across various other diseases. It currently has negative earnings. The Firm operates through two divisions: Supermarket Retail and Health Sciences.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.